This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowReprints and Permissions
Right arrow Copyright Information
Right arrow Books from ASM Press
Right arrow MicrobeWorld
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by DiRenzo, J.
Right arrow Articles by Glass, C. K.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by DiRenzo, J.
Right arrow Articles by Glass, C. K.

 Previous Article  |  Next Article 

Mol. Cell. Biol., 04 1997, 2166-2176, Vol 17, No. 4
Copyright © 1997, American Society for Microbiology

Peroxisome proliferator-activated receptors and retinoic acid receptors differentially control the interactions of retinoid X receptor heterodimers with ligands, coactivators, and corepressors

J DiRenzo, M Soderstrom, R Kurokawa, MH Ogliastro, M Ricote, S Ingrey, A Horlein, MG Rosenfeld and CK Glass
Department of Medicine, University of California, San Diego, La Jolla 92093-0651, USA.

As the obligate member of most nuclear receptor heterodimers, retinoid X receptors (RXRs) can potentially perform two functions: cooperative binding to hormone response elements and coordinate regulation of target genes by RXR ligands. In this paper we describe allosteric interactions between RXR and two heterodimeric partners, retinoic acid receptors (RARs) and peroxisome proliferator-activated receptors (PPARs); RARs and PPARs prevent and permit activation by RXR-specific ligands, respectively. By competing for dimerization with RXR on response elements consisting of direct-repeat half-sites spaced by 1 bp (DR1 elements), the relative abundance of RAR and PPAR determines whether the RXR signaling pathway will be functional. In contrast to RAR, which prevents the binding of RXR ligands and recruits the nuclear receptor corepressor N-CoR, PPAR permits the binding of SRC-1 in response to both RXR and PPAR ligands. Overexpression of SRC-1 markedly potentiates ligand-dependent transcription by PPARgamma, suggesting that SRC-1 serves as a coactivator in vivo. Remarkably, the ability of RAR to both block the binding of ligands to RXR and interact with corepressors requires the CoR box, a structural motif residing in the N- terminal region of the RAR ligand binding domain. Mutations in the CoR box convert RAR from a nonpermissive to a permissive partner of RXR signaling on DR1 elements. We suggest that the differential recruitment of coactivators and corepressors by RAR-RXR and PPAR-RXR heterodimers provides the basis for a transcriptional switch that may be important in controlling complex programs of gene expression, such as adipocyte differentiation.


This article has been cited by other articles:

  • Ehrenborg, E., Krook, A. (2009). Regulation of Skeletal Muscle Physiology and Metabolism by Peroxisome Proliferator-Activated Receptor {delta}. Pharmacol. Rev. 61: 373-393 [Abstract] [Full Text]  
  • Saraf, S., Nishtala, S., Parretti, H., Capps, N., Ramachandran, S. (2009). Paradoxical fall in HDL cholesterol observed in a patient treated with rosiglitazone and pioglitazone. British Journal of Diabetes & Vascular Disease 9: 186-189  
  • Mascrez, B., Ghyselinck, N. B., Chambon, P., Mark, M. (2009). A transcriptionally silent RXR{alpha} supports early embryonic morphogenesis and heart development. Proc. Natl. Acad. Sci. USA 106: 4272-4277 [Abstract] [Full Text]  
  • Lefterova, M. I., Zhang, Y., Steger, D. J., Schupp, M., Schug, J., Cristancho, A., Feng, D., Zhuo, D., Stoeckert, C. J. Jr., Liu, X. S., Lazar, M. A. (2008). PPAR{gamma} and C/EBP factors orchestrate adipocyte biology via adjacent binding on a genome-wide scale. Genes Dev. 22: 2941-2952 [Abstract] [Full Text]  
  • Giger, J., Qin, A. X., Bodell, P. W., Baldwin, K. M., Haddad, F. (2007). Activity of the beta-myosin heavy chain antisense promoter responds to diabetes and hypothyroidism. Am. J. Physiol. Heart Circ. Physiol. 292: H3065-H3071 [Abstract] [Full Text]  
  • Michalik, L., Auwerx, J., Berger, J. P., Chatterjee, V. K., Glass, C. K., Gonzalez, F. J., Grimaldi, P. A., Kadowaki, T., Lazar, M. A., O'Rahilly, S., Palmer, C. N. A., Plutzky, J., Reddy, J. K., Spiegelman, B. M., Staels, B., Wahli, W. (2006). International Union of Pharmacology. LXI. Peroxisome Proliferator-Activated Receptors. Pharmacol. Rev. 58: 726-741 [Abstract] [Full Text]  
  • Lu, D., Cottam, H. B., Corr, M., Carson, D. A. (2005). Repression of {beta}-catenin function in malignant cells by nonsteroidal antiinflammatory drugs. Proc. Natl. Acad. Sci. USA 102: 18567-18571 [Abstract] [Full Text]  
  • Kim, J., Yang, P., Suraokar, M., Sabichi, A. L., Llansa, N. D., Mendoza, G., Subbarayan, V., Logothetis, C. J., Newman, R. A., Lippman, S. M., Menter, D. G. (2005). Suppression of Prostate Tumor Cell Growth by Stromal Cell Prostaglandin D Synthase-Derived Products. Cancer Res. 65: 6189-6198 [Abstract] [Full Text]  
  • Sharma, C., Pradeep, A., Wong, L., Rana, A., Rana, B. (2004). Peroxisome Proliferator-activated Receptor {gamma} Activation Can Regulate {beta}-Catenin Levels via a Proteasome-mediated and Adenomatous Polyposis Coli-independent Pathway. J. Biol. Chem. 279: 35583-35594 [Abstract] [Full Text]  
  • Lim, H. J., Moon, I., Han, K. (2004). Transcriptional Cofactors Exhibit Differential Preference toward Peroxisome Proliferator-Activated Receptors {alpha} and {delta} in Uterine Cells. Endocrinology 145: 2886-2895 [Abstract] [Full Text]  
  • Leow, M. K. S., Addy, C. L., Mantzoros, C. S. (2003). Human Immunodeficiency Virus/Highly Active Antiretroviral Therapy-Associated Metabolic Syndrome: Clinical Presentation, Pathophysiology, and Therapeutic Strategies. J. Clin. Endocrinol. Metab. 88: 1961-1976 [Full Text]  
  • Gauthier, A., Vassiliou, G., Benoist, F., McPherson, R. (2003). Adipocyte Low Density Lipoprotein Receptor-related Protein Gene Expression and Function Is Regulated by Peroxisome Proliferator-activated Receptor gamma. J. Biol. Chem. 278: 11945-11953 [Abstract] [Full Text]  
  • Wick, M., Hurteau, G., Dessev, C., Chan, D., Geraci, M. W., Winn, R. A., Heasley, L. E., Nemenoff, R. A. (2002). Peroxisome Proliferator-Activated Receptor-gamma Is a Target of Nonsteroidal Anti-Inflammatory Drugs Mediating Cyclooxygenase-Independent Inhibition of Lung Cancer Cell Growth. Mol. Pharmacol. 62: 1207-1214 [Abstract] [Full Text]  
  • Lee, G., Elwood, F., McNally, J., Weiszmann, J., Lindstrom, M., Amaral, K., Nakamura, M., Miao, S., Cao, P., Learned, R. M., Chen, J.-L., Li, Y. (2002). T0070907, a Selective Ligand for Peroxisome Proliferator-activated Receptor gamma , Functions as an Antagonist of Biochemical and Cellular Activities. J. Biol. Chem. 277: 19649-19657 [Abstract] [Full Text]  
  • Akiyama, T. E., Baumann, C. T., Sakai, S., Hager, G. L., Gonzalez, F. J. (2002). Selective Intranuclear Redistribution of PPAR Isoforms by RXR{alpha}. Mol. Endocrinol. 16: 707-721 [Abstract] [Full Text]  
  • Shi, Y., Hon, M., Evans, R. M. (2002). The peroxisome proliferator-activated receptor delta , an integrator of transcriptional repression and nuclear receptor signaling. Proc. Natl. Acad. Sci. USA 10.1073/pnas.052707099v1 [Abstract] [Full Text]  
  • Aranda, A., Pascual, A. (2001). Nuclear Hormone Receptors and Gene Expression. Physiol. Rev. 81: 1269-1304 [Abstract] [Full Text]  
  • Baumann, C. T., Ma, H., Wolford, R., Reyes, J. C, Maruvada, P., Lim, C., Yen, P. M., Stallcup, M. R., Hager, G. L. (2001). The Glucocorticoid Receptor Interacting Protein 1 (GRIP1) Localizes in Discrete Nuclear Foci That Associate with ND10 Bodies and Are Enriched in Components of the 26S Proteasome. Mol. Endocrinol. 15: 485-500 [Abstract] [Full Text]  
  • Padilla, J., Kaur, K., Cao, H. J., Smith, T. J., Phipps, R. P. (2000). Peroxisome Proliferator Activator Receptor-{gamma} Agonists and 15-Deoxy-{Delta}12,1412,14-PGJ2 Induce Apoptosis in Normal and Malignant B-Lineage Cells. J. Immunol. 165: 6941-6948 [Abstract] [Full Text]  
  • Helledie, T., Antonius, M., Sørensen, R. V., Hertzel, A. V., Bernlohr, D. A., Kølvraa, S., Kristiansen, K., Mandrup, S. (2000). Lipid-binding proteins modulate ligand-dependent trans-activation by peroxisome proliferator-activated receptors and localize to the nucleus as well as the cytoplasm. J. Lipid Res. 41: 1740-1751 [Abstract] [Full Text]  
  • Yang, W., Rachez, C., Freedman, L. P. (2000). Discrete Roles for Peroxisome Proliferator-Activated Receptor gamma and Retinoid X Receptor in Recruiting Nuclear Receptor Coactivators. Mol. Cell. Biol. 20: 8008-8017 [Abstract] [Full Text]  
  • Shao, G., Heyman, R. A., Schulman, I. G. (2000). Three Amino Acids Specify Coactivator Choice By Retinoid X Receptors. Mol. Endocrinol. 14: 1198-1209 [Abstract] [Full Text]  
  • Rodríguez, C., Noé, V., Cabrero, A., Ciudad, C. J., Laguna, J. C. (2000). Differences in the Formation of PPARalpha -RXR/acoPPRE Complexes between Responsive and Nonresponsive Species upon Fibrate Administration. Mol. Pharmacol. 58: 185-193 [Abstract] [Full Text]  
  • Marrapodi, M., Chiang, J. Y. L. (2000). Peroxisome proliferator-activated receptor {alpha} (PPAR{alpha}) and agonist inhibit cholesterol 7{alpha}-hydroxylase gene (CYP7A1) transcription. J. Lipid Res. 41: 514-520 [Abstract] [Full Text]  
  • Marrapodi, M., Chiang, J. Y. L. (2000). Peroxisome proliferator-activated receptor {alpha} (PPAR{alpha}) and agonist inhibit cholesterol 7{alpha}-hydroxylase gene (CYP7A1) transcription. J. Lipid Res. 41: 514-520 [Abstract] [Full Text]  
  • Chen, S., Johnson, B. A., Li, Y., Aster, S., McKeever, B., Mosley, R., Moller, D. E., Zhou, G. (2000). Both Coactivator LXXLL Motif-dependent and -independent Interactions Are Required for Peroxisome Proliferator-activated Receptor gamma (PPARgamma ) Function. J. Biol. Chem. 275: 3733-3736 [Abstract] [Full Text]  
  • Kassam, A., Winrow, C. J., Fernandez-Rachubinski, F., Capone, J. P., Rachubinski, R. A. (2000). The Peroxisome Proliferator Response Element of the Gene Encoding the Peroxisomal beta -Oxidation Enzyme Enoyl-CoA Hydratase/3-Hydroxyacyl-CoA Dehydrogenase Is a Target for Constitutive Androstane Receptor beta /9-cis-Retinoic Acid Receptor-mediated Transactivation. J. Biol. Chem. 275: 4345-4350 [Abstract] [Full Text]  
  • Rohde, C. M., Manatt, M., Clagett-Dame, M., DeLuca, H. F. (1999). Vitamin A Antagonizes the Action of Vitamin D in Rats. J. Nutr. 129: 2246-2250 [Abstract] [Full Text]  
  • Desvergne, B., Wahli, W. (1999). Peroxisome Proliferator-Activated Receptors: Nuclear Control of Metabolism. Endocr. Rev. 20: 649-688 [Abstract] [Full Text]  
  • Monden, T., Kishi, M., Hosoya, T., Satoh, T., Wondisford, F. E., Hollenberg, A. N., Yamada, M., Mori, M. (1999). p120 Acts as a Specific Coactivator for 9-cis-Retinoic Acid Receptor (RXR) on Peroxisome Proliferator-Activated Receptor-{gamma}/RXR Heterodimers. Mol. Endocrinol. 13: 1695-1703 [Abstract] [Full Text]  
  • Zhu, L., Bisgaier, C. L., Aviram, M., Newton, R. S. (1999). 9-cis Retinoic Acid Induces Monocyte Chemoattractant Protein-1 Secretion in Human Monocytic THP-1 Cells. Arterioscler. Thromb. Vasc. Bio. 19: 2105-2111 [Abstract] [Full Text]  
  • Kassam, A., Capone, J. P., Rachubinski, R. A. (1999). Orphan Nuclear Hormone Receptor RevErbalpha Modulates Expression from the Promoter of the Hydratase-dehydrogenase Gene by Inhibiting Peroxisome Proliferator-activated Receptor alpha -Dependent Transactivation. J. Biol. Chem. 274: 22895-22900 [Abstract] [Full Text]  
  • Wiebel, F. F., Steffensen, K. R., Treuter, E., Feltkamp, D., Gustafsson, J.-A. (1999). Ligand-Independent Coregulator Recruitment by the Triply Activatable OR1/Retinoid X Receptor-{alpha} Nuclear Receptor Heterodimer. Mol. Endocrinol. 13: 1105-1118 [Abstract] [Full Text]  
  • Lim, H., Gupta, R. A., Ma, W.-g., Paria, B. C., Moller, D. E., Morrow, J. D., DuBois, R. N., Trzaskos, J. M., Dey, S. K. (1999). Cyclo-oxygenase-2-derived prostacyclin mediates embryo implantation in the mouse via PPARdelta. Genes Dev. 13: 1561-1574 [Abstract] [Full Text]  
  • Heinlein, C. A., Ting, H.-J., Yeh, S., Chang, C. (1999). Identification of ARA70 as a Ligand-enhanced Coactivator for the Peroxisome Proliferator-activated Receptor gamma. J. Biol. Chem. 274: 16147-16152 [Abstract] [Full Text]  
  • Johnson, B. S., Chandraratna, R. A. S., Heyman, R. A., Allegretto, E. A., Mueller, L., Collins, S. J. (1999). Retinoid X Receptor (RXR) Agonist-Induced Activation of Dominant-Negative RXR-Retinoic Acid Receptor alpha 403 Heterodimers Is Developmentally Regulated during Myeloid Differentiation. Mol. Cell. Biol. 19: 3372-3382 [Abstract] [Full Text]  
  • Feltkamp, D., Wiebel, F. F., Alberti, S., Gustafsson, J.-A. (1999). Identification of a Novel DNA Binding Site for Nuclear Orphan Receptor OR1. J. Biol. Chem. 274: 10421-10429 [Abstract] [Full Text]  
  • Gelman, L., Zhou, G., Fajas, L., Raspe, E., Fruchart, J.-C., Auwerx, J. (1999). p300 Interacts with the N- and C-terminal Part of PPARgamma 2 in a Ligand-independent and -dependent Manner, Respectively. J. Biol. Chem. 274: 7681-7688 [Abstract] [Full Text]  
  • Treuter, E., Johansson, L., Thomsen, J. S., Warnmark, A., Leers, J., Pelto-Huikko, M., Sjoberg, M., Wright, A. P. H., Spyrou, G., Gustafsson, J.-A. (1999). Competition between Thyroid Hormone Receptor-associated Protein (TRAP) 220 and Transcriptional Intermediary Factor (TIF) 2 for Binding to Nuclear Receptors. IMPLICATIONS FOR THE RECRUITMENT OF TRAP AND p160 COACTIVATOR COMPLEXES. J. Biol. Chem. 274: 6667-6677 [Abstract] [Full Text]  
  • Berger, J., Leibowitz, M. D., Doebber, T. W., Elbrecht, A., Zhang, B., Zhou, G., Biswas, C., Cullinan, C. A., Hayes, N. S., Li, Y., Tanen, M., Ventre, J., Wu, M. S., Berger, G. D., Mosley, R., Marquis, R., Santini, C., Sahoo, S. P., Tolman, R. L., Smith, R. G., Moller, D. E. (1999). Novel Peroxisome Proliferator-activated Receptor (PPAR) gamma  and PPARdelta Ligands Produce Distinct Biological Effects. J. Biol. Chem. 274: 6718-6725 [Abstract] [Full Text]  
  • Saladin, R., Fajas, L., Dana, S., Halvorsen, Y.-D., Auwerx, J., Briggs, M. (1999). Differential Regulation of Peroxisome Proliferator Activated Receptor {{gamma}}1 (PPAR{{gamma}}1) and PPAR{{gamma}}2 Messenger RNA Expression in the Early Stages of Adipogenesis. Cell Growth Differ. 10: 43-48 [Abstract] [Full Text]  
  • Winrow, C. J., Capone, J. P., Rachubinski, R. A. (1998). Cross-talk between Orphan Nuclear Hormone Receptor RZRalpha and Peroxisome Proliferator-activated Receptor alpha  in Regulation of the Peroxisomal Hydratase-Dehydrogenase Gene. J. Biol. Chem. 273: 31442-31448 [Abstract] [Full Text]  
  • Hsu, M.-H., Palmer, C. N. A., Song, W., Griffin, K. J., Johnson, E. F. (1998). A Carboxyl-terminal Extension of the Zinc Finger Domain Contributes to the Specificity and Polarity of Peroxisome Proliferator-activated Receptor DNA Binding. J. Biol. Chem. 273: 27988-27997 [Abstract] [Full Text]  
  • Tolon, R. M., Castillo, A. I., Aranda, A. (1998). Activation of the Prolactin Gene by Peroxisome Proliferator-activated Receptor-alpha Appears to Be DNA Binding-independent. J. Biol. Chem. 273: 26652-26661 [Abstract] [Full Text]  
  • Zhou, G., Cummings, R., Li, Y., Mitra, S., Wilkinson, H. A., Elbrecht, A., Hermes, J. D., Schaeffer, J. M., Smith, R. G., Moller, D. E. (1998). Nuclear Receptors Have Distinct Affinities for Coactivators: Characterization by Fluorescence Resonance Energy Transfer. Mol. Endocrinol. 12: 1594-1604 [Abstract] [Full Text]  
  • Kurtz, T. W., Gardner, D. G. (1998). Transcription-Modulating Drugs : A New Frontier in the Treatment of Essential Hypertension. Hypertension 32: 380-386 [Abstract] [Full Text]  
  • Schulman, I. G., Shao, G., Heyman, R. A. (1998). Transactivation by Retinoid X Receptor-Peroxisome Proliferator-Activated Receptor gamma  (PPARgamma ) Heterodimers: Intermolecular Synergy Requires Only the PPARgamma Hormone-Dependent Activation Function. Mol. Cell. Biol. 18: 3483-3494 [Abstract] [Full Text]  
  • Treuter, E., Albrektsen, T., Johansson, L., Leers, J., Gustafsson, J.-A. (1998). A Regulatory Role for RIP140 in Nuclear Receptor Activation. Mol. Endocrinol. 12: 864-881 [Abstract] [Full Text]  
  • Towers, T. L., Freedman, L. P. (1998). Granulocyte-Macrophage Colony-stimulating Factor Gene Transcription Is Directly Repressed by the Vitamin D3 Receptor. IMPLICATIONS FOR ALLOSTERIC INFLUENCES ON NUCLEAR RECEPTOR STRUCTURE AND FUNCTION BY A DNA ELEMENT. J. Biol. Chem. 273: 10338-10348 [Abstract] [Full Text]  
  • Dowell, P., Ishmael, J. E., Avram, D., Peterson, V. J., Nevrivy, D. J., Leid, M. (1997). p300 Functions as a Coactivator for the Peroxisome Proliferator-activated Receptor alpha. J. Biol. Chem. 272: 33435-33443 [Abstract] [Full Text]  
  • Li, H., Leo, C., Schroen, D. J., Chen, J. D. (1997). Characterization of Receptor Interaction and Transcriptional Repression by the Corepressor SMRT. Mol. Endocrinol. 11: 2025-2037 [Abstract] [Full Text]  
  • Wade, D. P., Puckey, L. H., Knight, B. L., Acquati, F., Mihalich, A., Taramelli, R. (1997). Characterization of Multiple Enhancer Regions Upstream of the Apolipoprotein(a) Gene. J. Biol. Chem. 272: 30387-30399 [Abstract] [Full Text]  
  • IJpenberg, A., Jeannin, E., Wahli, W., Desvergne, B. (1997). Polarity and Specific Sequence Requirements of Peroxisome Proliferator-activated Receptor (PPAR)/Retinoid X Receptor Heterodimer Binding to DNA. A FUNCTIONAL ANALYSIS OF THE MALIC ENZYME GENE PPAR RESPONSE ELEMENT. J. Biol. Chem. 272: 20108-20117 [Abstract] [Full Text]  
  • Li, H., Gomes, P. J., Chen, J. D. (1997). RAC3, a steroid/nuclear receptor-associated coactivator that is related to SRC-1 and TIF2. Proc. Natl. Acad. Sci. USA 94: 8479-8484 [Abstract] [Full Text]  
  • Hansen, J. B., Zhang, H., Rasmussen, T. H., Petersen, R. K., Flindt, E. N., Kristiansen, K. (2001). Peroxisome Proliferator-activated Receptor delta (PPARdelta )-mediated Regulation of Preadipocyte Proliferation and Gene Expression Is Dependent on cAMP Signaling. J. Biol. Chem. 276: 3175-3182 [Abstract] [Full Text]  
  • Jones, D. C., Ding, X., Daynes, R. A. (2002). Nuclear Receptor Peroxisome Proliferator-activated Receptor alpha (PPARalpha ) Is Expressed in Resting Murine Lymphocytes. THE PPARalpha IN T AND B LYMPHOCYTES IS BOTH TRANSACTIVATION AND TRANSREPRESSION COMPETENT. J. Biol. Chem. 277: 6838-6845 [Abstract] [Full Text]  
  • Rosen, E. D., Spiegelman, B. M. (2001). PPARgamma : a Nuclear Regulator of Metabolism, Differentiation, and Cell Growth. J. Biol. Chem. 276: 37731-37734 [Full Text]  
  • Shi, Y., Hon, M., Evans, R. M. (2002). The peroxisome proliferator-activated receptor delta , an integrator of transcriptional repression and nuclear receptor signaling. Proc. Natl. Acad. Sci. USA 99: 2613-2618 [Abstract] [Full Text]  


Copyright © 2009 by the American Society for Microbiology.   For an alternate route to Journals.ASM.org, visit: http://intl-journals.asm.org | More Info»